Monday, August 15, 2016

BRIEF-Actelion wins Swiss approval of uptravi for form of high blood pressure

* Says receives Swissmedic approval for uptravi (selexipag)

for treatment of pulmonary arterial hypertension

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)